Justin Leong

CIK: 0001825782

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RMD

RESMED INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

RMD
RESMED INC
Aug 14, 2026
Award(A)
Direct
6.5K shares-
RMD
RESMED INC
Nov 20, 2025
Award(A)
Direct
1.8K shares-
RMD
RESMED INC
Aug 15, 2025
Award(A)
Direct
5.5K shares-
RMD
RESMED INC
Nov 22, 2024
Sale(S)
Direct
6.2K shares at avg. $243.09$1.5M

		Type	Shares	Price		Ownership
Aug 14, 2026	RMD RESMED INC	Award(A)	6,461	-	$0	Direct
Nov 20, 2025	RMD RESMED INC	Award(A)	1,848	-	-	Direct
Aug 15, 2025	RMD RESMED INC	Award(A)	5,462	-	-	Direct
Nov 22, 2024	RMD RESMED INC	Sale(S)	6,160	$243.09	$1,497,416	Direct

1-4 of 4 transactions

About Leong Justin

Leong Justin (SEC CIK 0001825782) files insider reports with the SEC as Chief Product Officer of RESMED INC (RMD).

Signal8 holds 4 ownership filings by Leong Justin, all Form 4s, filed between Nov 25, 2024 and Oct 1, 2026. Those filings report 4 transactions, from Nov 22, 2024 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Leong Justin's filings is in SAN DIEGO, CA.

Recent filings by Leong Justin

Aug 14, 2026: Grant or award of RMD shares (Form 4, code A).
Nov 20, 2025: Grant or award of RMD shares (Form 4, code A).
Aug 15, 2025: Grant or award of RMD shares (Form 4, code A).
Nov 22, 2024: Open-market sale of RMD shares (Form 4, code S).

Other insiders filing for RESMED INC (RMD)

Rider Michael J, Global General Counsel
Farrell Michael J., Chairman and CEO
Bloomer Aaron, Chief Financial Officer
FARRELL PETER C, Director
Sandercock Brett, Chief Financial Officer
De Witte Jan, Director

How to read Form 4 transaction codes